Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma
Top Cited Papers
- 1 July 2003
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 125 (1) , 89-97
- https://doi.org/10.1016/s0016-5085(03)00689-9
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamineOncogene, 2002
- Glypican-3 expression is silenced in human breast cancerOncogene, 2001
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Invasiveness of Hepatocellular Carcinoma Cell Lines: Contribution of Hepatocyte Growth Factor, c-met, and Transcription Factor Ets-1Biochemical and Biophysical Research Communications, 2001
- Resection of Hepatocellular Carcinoma Without Preoperative Tumor BiopsyAnnals of Surgery, 2001
- Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV statusPublished by Elsevier ,2001
- Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesotheliomaOncogene, 2000
- Functions of Cell Surface Heparan Sulfate ProteoglycansAnnual Review of Biochemistry, 1999
- Global cancer statisticsCA: A Cancer Journal for Clinicians, 1999
- The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.Journal of Clinical Investigation, 1998